FMC stock highlights October 19 ASN research pre-market
Published on 10/20/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming reporting date
- Fresenius Medical Care presented new scientific findings and innovations at ASN Kidney Week on October 19, 2026.
- The company is scheduled to publish its third-quarter 2026 results on November 3, 2026.
- FMC stock trades pre-market at EUR 39.16 at 7:59 a.m. CEST at Lang & Schwarz on October 20, 2026.
On October 19, 2026, Fresenius Medical Care presented new scientific findings and innovations at ASN Kidney Week 2026, according to its investor-relations page. FMC stock trades pre-market at EUR 39.16 at 7:59 a.m. CEST at Lang & Schwarz on October 20, 2026.
ASN Kidney Week update
The company’s October 19 newsroom item concerns scientific findings and innovations related to the further development of kidney care. The item is listed by Fresenius Medical Care in its investor-relations newsroom, which also identifies the company’s third-quarter reporting date as November 3, 2026.
Pre-market indication
At Lang & Schwarz, the stock was quoted at EUR 39.16 at 7:59 a.m. CEST on October 20, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of FMC stock.
Business and reporting calendar
Fresenius Medical Care operates in kidney care, including in-center hemodialysis, serving the renal-care market. The company’s investor-relations calendar lists third-quarter 2026 reporting for November 3, 2026, followed by publication of the quarterly financial report on November 6, 2026. Market context: Market report DAX.
